Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Christine Petti

Plastic Surgery Torrance, CA Medical Doctor

NPI 1568634285 CMS profile 252567

23365 Hawthorne Blvd Ste 102, Torrance, CA 90505

Open in the dashboard

General payments

$2,577

66 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$10,704 paid to institutions, not to them · program years 2019–2020

Through program year 2025, Christine Petti of Torrance, CA is reported in the CMS Open Payments database as having received $2,577 across 66 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $10,704 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 56th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $182 6
2024 General $263 6
2023 General $507 11
2022 General $429 15
2021 General $304 6
2020 General $490 14
2019 General $402 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christine Petti
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Christine Petti were reported at $182. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Christine Petti Plastic Surgery median Middle half National median
2019 $402 $371 $122–$1,483 $163
2020 $490 $158 $52–$438 $114
2021 $304 $249 $87–$752 $132
2022 $429 $274 $102–$793 $149
2023 $507 $299 $113–$891 $160
2024 $263 $361 $124–$1,062 $164
2025 $182 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $426 14 payments
  2. Galderma Laboratories, L.P. $391 10 payments
  3. Seattle Genetics, Inc. $240 2 payments
  4. Allergan Inc. $232 9 payments
  5. AstraZeneca Pharmaceuticals LP $204 2 payments
  6. Genzyme Corporation $169 4 payments
  7. Medtronic, Inc. $155 1 payment
  8. Genentech USA, Inc. $150 1 payment
  9. UCB, Inc. $146 7 payments
  10. E.R. Squibb & Sons, L.L.C. $92 1 payment
  11. Other $373 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,427 65 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $150 1 payment
Products named General payments · program years 2019–2025
  1. TUKYSA $240 2 payments
  2. LigaSure $155 1 payment
  3. TECENTRIQ $150 1 payment
  4. Herceptin $150 1 payment
  5. Cimzia $146 7 payments
  6. IMFINZI Oncology $125 1 payment
  7. SARCLISA $101 1 payment
  8. NATRELLE $93 2 payments
  9. OPDIVO $92 1 payment
  10. IMFINZI Cardiovascular And Metabolism $79 1 payment
  11. Other $872 41 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

68

Median for Plastic Surgery: 39

Drug cost

$603

Median for Plastic Surgery: $219

Branded share of claims

52.9%

Median for Plastic Surgery: 30%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Cephalexin Generic 17 $217
Valacyclovir Valacyclovir Hcl Brand 11 $142
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 13 $135
Ondansetron Odt Ondansetron Brand 12 $60
Alprazolam Generic 15 $49

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 700 Part D prescribers listed as Plastic Surgery; they describe a distribution and say nothing about conduct.

Records

66 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record